Is KMB Worth Buying as Low Valuation Meets China and Growth Risks?

Kimberly-Clark Corporation KMB offers investors a valuation-versus-execution trade-off. The stock trades below key historical and market benchmarks while the company continues to post volume-and-mix gains and margin improvement. 

That discount is balanced by slower category growth, consumer pressure and disruption in China. The current setup supports patience rather than a clear-cut buying case.

KMB's Valuation Discount Strengthens the Bull Case

KMB trades at 14.75X forward 12-month earnings, below 18.28X for the industry, 16.81X for the Zacks Consumer Staples sector and 20.69X for the S&P 500. Its multiple is also below the one-year median of 14.63X, though above the one-year low of 12.52X.

Image Source: Zacks Investment Research

The discount gives investors a lower entry valuation relative to those benchmarks, but it does not erase execution risk. Consumer-staples peers Colgate-Palmolive Company CL and Church & Dwight Co., Inc. CHD provide useful comparison points for investors weighing KMB's valuation, growth profile and execution risks.

Kimberly-Clark's Volume-Mix Engine Is Holding

Kimberly-Clark delivered its 10th consecutive quarter of positive volume-plus-mix performance. In the first half of 2026, organic sales rose 1.2%, supported by 1.3% volume growth and a 0.4% mix benefit, partly offset by a 0.5% decline in net pricing.

North America has generated volume-plus-mix-led growth in eight of the past 10 quarters. Trailing 12-month share gains covered 70% of its North American sales base, giving the company a demand foundation as category growth moderates.

KMB's Productivity Is Protecting Margins

Gross productivity reached 6.4% in the second quarter of 2026. Adjusted gross margin expanded 190 basis points year over year to 38.8%.

Adjusted operating profit increased 6.2% to $757 million as productivity savings, one-time tariff refunds and favorable currency effects outweighed other pressures. That cost discipline is important because Kimberly-Clark continues to invest in product trial, brand support and supply-chain initiatives.

KMB's EPS Picture Shows Growth, but Estimates Stay Soft

Kimberly-Clark reported second-quarter 2026 adjusted earnings from continuing operations of $1.80 per share, up 10.4% year over year, but below the Zacks Consensus Estimate of $2.00. Adjusted earnings attributable to Kimberly-Clark were $2.12 per share, also up 10.4%, helped by higher adjusted operating profit and income from discontinued operations.

Kimberly-Clark Corporation Price, Consensus and EPS Surprise

Kimberly-Clark Corporation price-consensus-eps-surprise-chart | Kimberly-Clark Corporation Quote

For 2026, Kimberly-Clark expects adjusted EPS from continuing operations to grow at a high-single-digit rate on a constant-currency basis, including an approximately 30% increase in income from equity companies. However, adjusted EPS attributable to Kimberly-Clark is expected to decline at a low-single-digit rate, reflecting a more complicated earnings mix following portfolio changes.

China and Consumer Pressure Cloud KMB's Outlook

The China diaper disruption reduced consolidated organic sales growth by about 50 basis points and created an approximately 440-basis-point headwind to International Personal Care operating profit. Management expects the issue to continue affecting sales and profits in the near term. 

North American weighted category growth slowed to 1.9% from 3.7% sequentially, while lower-income consumers remain pressured.

KMB's Financial Position Supports Its Transformation

Kimberly-Clark ended the quarter with $956 million in cash and cash equivalents and $6.474 billion in long-term debt. Cash provided by operations totaled $1.653 billion in the first six months of 2026.

Capital spending reached $776 million during the period, while dividends returned $843 million to shareholders. The cash generation gives Kimberly-Clark resources to fund investment while it advances portfolio and operational changes.

KMB's Ranking Picture Remains Incomplete

The bottom line is balanced. KMB's valuation discount, sustained volume-and-mix momentum and productivity gains support the case for holding the shares, but China disruption, softer category growth and a reduced 2026 outlook limit the near-term argument for aggressive buying.

KMB currently carries a Zacks Rank #3 (Hold), along with a Value Score of C, a Growth Score of C, a Momentum Score of F and a VGM Score of C. Rank #3 can support holding an existing position, while the middling Value, Growth and VGM Scores and weak Momentum Score do not add a strong style-based buying signal. Investors may prefer to wait for clearer evidence of sales normalization and steadier category trends. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research